This reactivity was with the p17, p24 and gp160 viral antigens, which confirms that CFCs were contaminated with blood products from HIV-seropositive donors (data not shown). of plasma antibodies reactive with HIV proteins were detectable in Grosvenorine 87% (13/15) of the haemophiliacs tested. None of those individuals are presently positive for HIV proviral DNA as assessed by polymerase chain reaction (PCR). == Summary == Our data suggest that some severe hemophiliacs with weighty exposure to infectious HIV contaminated CFC experienced only transient low-level humoral immune reactions reactive with HIV antigens yet remained HIV-negative and apparently uninfected. Our data supports the possibility of HIV exposure without sustained illness and the living of HIV-natural resistance in some individuals. == Background == In the 1980’s an estimated 17,000 people in the United States were affected the congenital blood clotting element deficiencies, Hemophilia A and B (Element VIII and Element IX deficiency, respectively). Since the early 1970’s, the mainstay of treatment for bleeding in hemophilia individuals has been the use of clotting element concentrates (CFCs) commercially prepared from large plasma pools comprised of thousands of individual donors. Prior to 1985 CFCs were prepared from donors with unfamiliar HIV illness status and were not routinely subjected to viral inactivation methods. With each infusion from a new lot of clotting element concentrate, hemophilia individuals were exposed to plasma from approximately 2,000 to 25,000 donors [1]. As a result, roughly 50% of the total hemophilia population in the United States became infected with HIV prior to the institution of donor screening and the use of viral inactivation methods of element concentrates in 1985 [2-4]. Since 1987 there has been a virtual removal of HIV-1 illness in the hemophilia populace Grosvenorine [3-6]. Mainly due to the considerable network Grosvenorine of comprehensive hemophilia treatment centers, the hemophilia populace has been actively analyzed for possible variables that may influence HIV illness and progression. Retrospective analysis of hemophiliac plasma samples stored as part of routine clinical appointments has shown that HIV illness, as recorded by Grosvenorine long term HIV-seroconversions began in 1978, peaked in 1982, and ended by 1987. In general, those individuals who received the greatest exposure to CFCs were at the highest risk for HIV illness [7]. Hemophiliacs exposed to factor-VIII concentrates, in general, were more likely to become infected than those exposed Grosvenorine to factor-IX concentrates (prothrombin complex concentrates or PCCs). Individuals who received an average of over 20,000 models of factor-VIII concentrate annually during the early 1980’s experienced a cumulative incidence of HIV-infection exceeding 90% and those receiving comparable doses of PCCs experienced a cumulative incidence exceeding 50% [3,4]. This clearly demonstrates the prevalence of infectious HIV in the United States CFC supply. Not all hemophiliacs exposed to CFCs contaminated with infectious HIV were ultimately infected with the HIV computer virus. Although inoculum size may account for the lack of illness in some hemophiliacs, factors such as age, race, sex or pre-existing medical condition has not been found to be related to risk of HIV illness. However, several studies have shown that certain HLA types were associated with either an increased or decreased risk of HIV illness in hemophilia individuals [3,8-10]. In 1996, three self-employed groups recognized the chemokine co-receptor 5 (CCR-5) as a secondary receptor for the HIV computer IDH2 virus. The presence of two copies of a naturally happening deletion mutation of the CCR-5 receptor (CCR-532) apparently conferred resistance to illness by the computer virus [11-14]. Heterozygous manifestation of CCR-532 did not appear to prevent HIV-1 illness but may have resulted in slower decrease in CD4+ cells, lower levels of plasma viremia and in slower progression to AIDS [15-18]. From 19791985 severe hemophiliacs, as defined as individuals producing less than 1% of the normal value of a clotting element, were exposed to the largest volume of clotting element concentrates. Accordingly, 90% of these individuals became infected with HIV [4]. However, some severe hemophiliacs have remained H.